NASDAQ:ADIL | Free Cash Flow | ADIAL PHARMACEUTICALS, INC.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2017-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$1.61M
2025-12-31-$1.32M
2025-03-31-$1.59M
2024-12-31-$1.45M
2024-03-31-$1.63M
2023-12-31-$1.22M
2023-03-31-$2.3M
2022-12-31-$1.75M
2022-03-31-$2.5M
2021-12-31-$2.37M$0.00-$2.37M
2021-03-31-$2.84M$30,875.00-$2.87M
2020-12-31-$2.61M
2020-03-31-$1.83M
2019-12-31-$1.75M
2019-03-31-$1.72M
2018-12-31-$1.1M
2018-03-31-$214,282.00
2017-12-31-$122,102.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$6.49M
2024-12-31-$6.92M
2023-12-31-$6.81M
2022-12-31-$11.19M
2021-12-31-$11.95M$64,605.00-$12.01M
2020-12-31-$7.63M
2019-12-31-$6.34M
2018-12-31-$2.5M
2017-12-31-$494,862.00